Aardvark Therapeutics, Inc.AARD
Price (close)
$5.06
Market cap
$110.7M
P/E
—
Revenue (TTM)
$0
Net income
-$69.9M
Dividend yield
—
1-year total return
-60.1%
Net margin
—
Revenue growth
—
Debt / equity
—
What Aardvark Therapeutics, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | — | — | $0 |
| Net income | — | -$20.6M | -$57.6M |
| Free cash flow | — | -$18.2M | -$54.3M |
More on AARD.
- Aardvark Therapeutics, Inc. summary
- Aardvark Therapeutics, Inc. financial statements
- Aardvark Therapeutics, Inc. key metrics
- Aardvark Therapeutics, Inc. health scores and style box
- Aardvark Therapeutics, Inc. earnings
- Aardvark Therapeutics, Inc. dividends
- Aardvark Therapeutics, Inc. valuation
- Aardvark Therapeutics, Inc. ownership and insiders
- Aardvark Therapeutics, Inc. peers
Figures from Aardvark Therapeutics, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.